Version 2 of the Cochrane risk-of-bias tool for randomized controlled trials. by Solima Sabeel (9545738)

Subjects:

Analysis of randomized controlled trials stratified based on treatment duration. by Solima Sabeel (9545738)

Subjects:

PRISMA flow diagram of the systematic literature search process. by Solima Sabeel (9545738)

Subjects:

Excluded skewed studies. by Solima Sabeel (9545738)

Subjects:

Summary of randomized controlled trials. by Solima Sabeel (9545738)

Subjects:

Summary of non-randomized studies. by Solima Sabeel (9545738)

Subjects:

Summary table showing analysis of randomized controlled trials stratified based on age groups. by Solima Sabeel (9545738)

Subjects:

Prediction for the ecological functional composition of the bacterial community from Functional Annotation of Procaryotic Taxa (FAPROTAX) (A) and relationship between fertilization... by Qian Wang (32718)

S1 File - by Luqiong Liu (11537092)

“…Compared with LPS treatment alone, BA significantly mitigated the reduction in the TEER, decreased FD-4 flux permeability, increased the mRNA expression of ZO-1 and Occludin, and normalized the distribution of ZO-1 and Occludin in Caco2 cells. …”

Experimental treatments and groups. by Luqiong Liu (11537092)

“…Compared with LPS treatment alone, BA significantly mitigated the reduction in the TEER, decreased FD-4 flux permeability, increased the mRNA expression of ZO-1 and Occludin, and normalized the distribution of ZO-1 and Occludin in Caco2 cells. …”

Primers for RT-qPCR. by Luqiong Liu (11537092)

“…Compared with LPS treatment alone, BA significantly mitigated the reduction in the TEER, decreased FD-4 flux permeability, increased the mRNA expression of ZO-1 and Occludin, and normalized the distribution of ZO-1 and Occludin in Caco2 cells. …”

Narrow- and broad-band spectral changes after hemispherotomy in an awake representative patient, displaying marked electroencephalography (EEG) slowing of the isolated cortex. by Michele Angelo Colombo (22446342)

Wear morphology: (a) UT, (b) SP1, (c) SP2, and (d) SP3. by Huashen Guan (20454677)

Residual stress of various samples: (a) surface residual stress and (b) residual stress in the depth direction. by Huashen Guan (20454677)

Scaling of overall health burden with yearly expenditure growth. by Margherita Molaro (17803989)

Evolution of health burden and life expectancy under different expenditure scenarios. by Margherita Molaro (17803989)

Participant characteristics, overall and for each transition, of primary analytic sample (activity data for all 14 days of the respective transition period). by Shelby L. Sturrock (10751675)

Subjects:

Stereotactic injection of AAV-miR-129-5p attenuated microglia activation in depressed mice. by Qiaozhen Qin (13159201)

Impact on different areas of health. by Margherita Molaro (17803989)

Stereotactic injection of AAV-miR-129-5p suppressed astrocyte activation in depressed mice. by Qiaozhen Qin (13159201)